Synedica Klow 80mg Pen

The Synedica Klow 80mg Pen is an advanced, all-in-one multi-compound research injection pen engineered specifically for laboratory investigations. Formulated as a pre-mixed liquid solution, this prefilled pen eliminates manual powder reconstitution, sterile water handling, and syringe transfers.

Formulation Breakdown: Synedica Klow 80mg Multi-Compound Pen

Each Synedica Klow 80mg unit delivers a precise 80mg total blend combining five synergistic research agents:

• GHK-Cu (48mg): High-purity copper tripeptide investigated in tissue remodeling, collagen synthesis, and dermal repair mechanisms.

• BPC-157 (10mg): Cytoprotective pentadecapeptide studied for cellular regeneration and tissue recovery pathways.

• TB-500 (10mg): Synthetic Thymosin Beta-4 fragment evaluated for cell migration and tissue repair signaling.

• KPV (10mg): Tripeptide derivative researched for anti-inflammatory biological mechanisms.

• Vitamin B12 (2mg): Essential metabolic co-factor supporting cellular energy and enzymatic function.

Compound Synergy & Biological Research Pathways

The synedica klow 80mg matrix allows researchers to evaluate multiple regenerative and anti-inflammatory pathways within a single controlled administration. Rather than storing and measuring individual vials separately, the pre-formulated ratios ensure consistent batch-to-batch testing conditions.

Technical Specifications: Klow 80mg Pen Kit

Advantages of the Synedica Prefilled Pen System

Dial Precision & Zero Reconstitution

Traditional lyophilized vials carry potential risks of liquid handling errors or contamination during reconstitution. The klow 80mg pen utilizes an integrated mechanical dial mechanism, enabling researchers to select precise micro-doses with maximum repeatability and efficiency.

Quality Assurance & Verification

Every Synedica Labs production run is subjected to independent High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry testing to verify exact compound purity and molecular weight.